Safety, Tolerability and Efficacy Study With a Fixed-Dose Combination (FDC) Ketoprofen Plus Omeprazole
NCT00971581
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
52
Enrollment
INDUSTRY
Sponsor class
Conditions
Pain
Interventions
DRUG:
FDC KETOPROFEN+OMEPRAZOLE
Sponsor
Sanofi